162 related articles for article (PubMed ID: 2274081)
1. Inhibition of DNA biosynthesis by vincristine and pentoxifylline in murine P388 leukemia cells resistant to doxorubicin.
Chitnis MP; Viladkar AB; Juvekar AS
Neoplasma; 1990; 37(6):619-26. PubMed ID: 2274081
[TBL] [Abstract][Full Text] [Related]
2. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of pentoxifylline and doxorubicin on cell survival and DNA damage in sensitive and MDR-P388 leukemia cells.
Viladkar A; Chitnis M
Cancer Biother; 1994; 9(2):143-51. PubMed ID: 7812363
[TBL] [Abstract][Full Text] [Related]
4. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
Bankusli I; Yin MB; Mazzoni A; Abdellah AJ; Rustum YM
Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Ling YH; Priebe W; Perez-Soler R
Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
[TBL] [Abstract][Full Text] [Related]
7. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
Adwankar MK; Chitnis MP
Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178
[TBL] [Abstract][Full Text] [Related]
8. Effect of pentoxifylline on P-glycoprotein mediated vincristine resistance of L1210 mouse leukemic cell line.
Breier A; Barancík M; Stefanková Z; Uhrík B; Tribulová N
Neoplasma; 1994; 41(5):297-303. PubMed ID: 7854500
[TBL] [Abstract][Full Text] [Related]
9. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
[TBL] [Abstract][Full Text] [Related]
10. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
Ganapathi R; Grabowski D; Rouse W; Riegler F
Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
[TBL] [Abstract][Full Text] [Related]
13. Circumvention of drug resistance of P388/R cells by the combination of adriamycin and mitoxantrone with hyperthermia (42 degrees C).
Juvekar AS; Chitnis MP
Neoplasma; 1991; 38(2):207-11. PubMed ID: 2041579
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermia blocks reversibility of hydroxyurea and bipyridine induced synergistic inhibition of DNA biosynthesis in P388 murine leukemia cells.
Satyamoorthy K; Chitnis MP
Neoplasma; 1988; 35(2):153-9. PubMed ID: 3374706
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
Yamamoto S; Hui PZ; Fukuda Y; Tatsumi K; Mino M
Biochem Int; 1989 Jun; 18(6):1077-83. PubMed ID: 2751676
[TBL] [Abstract][Full Text] [Related]
16. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
17. Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta- phenethyl)amino]propyloxy)-benzenesulfonyl))indolizine.
Jaffrézou JP; Levade T; Chatelain P; Laurent G
Cancer Res; 1992 Dec; 52(23):6440-6. PubMed ID: 1423291
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
Hait WN; Pierson NR
Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
[TBL] [Abstract][Full Text] [Related]
19. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
Dekker K; Kojima N; Yamamoto S; Tatsumi K; Mino M; Yagi K
Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance of murine leukemia cells characterization and correlation with cytochrome P-450 dependent activities, cytosolic calcium and cell cycle state.
Pfeil D; Bergmann J; Fichtner I; Stein U; Hentschel M; Rothe I; Goan SR
Anticancer Res; 1994; 14(2A):571-6. PubMed ID: 7912495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
